SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 71 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $573,000 | +58.7% | 38,230 | +29.0% | 0.00% | – |
| Q1 2016 | $361,000 | -31.8% | 29,630 | -10.8% | 0.00% | – |
| Q4 2015 | $529,000 | -3.6% | 33,230 | -7.3% | 0.00% | – |
| Q3 2015 | $549,000 | -37.1% | 35,830 | -0.2% | 0.00% | -100.0% |
| Q2 2015 | $873,000 | +16.2% | 35,900 | +11.1% | 0.00% | 0.0% |
| Q1 2015 | $751,000 | -14.1% | 32,300 | -7.2% | 0.00% | 0.0% |
| Q4 2014 | $874,000 | -19.2% | 34,800 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,082,000 | +34.9% | 34,800 | +12.3% | 0.00% | 0.0% |
| Q2 2014 | $802,000 | +32.6% | 31,000 | +19.7% | 0.00% | 0.0% |
| Q1 2014 | $605,000 | -16.1% | 25,900 | -8.8% | 0.00% | 0.0% |
| Q4 2013 | $721,000 | +57.4% | 28,400 | +26.5% | 0.00% | – |
| Q3 2013 | $458,000 | -7.5% | 22,457 | -4.7% | 0.00% | -100.0% |
| Q2 2013 | $495,000 | – | 23,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |